SCM
TECH icon

Sandler Capital Management’s Bio-Techne TECH Stock Holding History

Sandler Capital Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-39,500
Closed -$2.2M – 192
2025
Q3 		$2.2M Sell
39,500
-7,800
-16% -$418K 0.65% 60
2025
Q2 		$2.43M Buy
+47,300
New +$2.38M 0.66% 60

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HBK Investments
HBK Investments Dallas, Texas $10.3B AUM 67.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Sandler Capital Management's TECH Position: Q2 2026 in Review

Sandler Capital Management sold out of Bio-Techne (TECH) in Q2 2026, closing a stake of 17,936 shares — an estimated $937K sold.

Sandler Capital Management first reported a position in TECH in Q2 2016 and held it in 35 quarters. The position peaked at $33.3M in Q3 2021. 597 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Sandler Capital Management reported no remaining Bio-Techne position as of Q2 2026 after selling out during the quarter.
  • Sandler Capital Management sold 17,936 Bio-Techne shares in Q2 2026, an estimated $937K.
  • Sandler Capital Management first reported a position in Bio-Techne in Q2 2016 and held it in 35 quarters.
  • Sandler Capital Management's Bio-Techne position peaked at $33.3M in Q3 2021.
  • 597 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Sandler Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.